REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuroeconomix Sas (Colombia)

Main Activities: All Other Professional, Scientific, and Technical Services
Full name: Neuroeconomix Sas Profile Updated: January 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

NeuroEconomix is a health economics and clinical epidemiology company that primarily serves the Latin American market. The company develops data analysis tools and conducts studies related to health outcomes research, pharmacoeconomics, and evidence-based medicine. Its offerings include literature reviews, economic evaluations, budget impact studies, and the adaptation of clinical practice guidelines. NeuroEconomix claims to utilize technologies associated with clinical epidemiology and Real World Evidence.

Headquarters
Carrera 23 122 88 Apartamento 203
Bogota D.C.; Bogota D.C; Postal Code: 1012

Contact Details: Purchase the Neuroeconomix Sas report to view the information.

Basic Information
Total Employees:
Purchase the Neuroeconomix Sas report to view the information.
Financial Auditors:
Purchase the Neuroeconomix Sas report to view the information.
Incorporation Date:
August 06, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Neuroeconomix Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
11.9%
Total Operating Revenue
11.9%
Operating Profit
58.18%
Net Profit/Loss for the Period
89.36%
Total Assets
81.6%
Total Equity
22.27%
Operating Profit Margin
1.13%
Net Profit Margin
1.31%
Return on Equity (ROE)
3.34%
Quick Ratio
-1.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?